Drug Eluting Balloon for Peripheral Artery Disease Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Drug-eluting balloons (DEB) are conventional semi-compliant angioplasty balloons covered with an anti-proliferative drug which is released into the vessel wall during inflation of the balloon, usually at nominal pressures with a specific minimal inflation time. Drug- eluting balloons (DEB) for Peripheral Artery Disease have been introduced to improve patency rates following endovascular intervention for lower extremity PAD (Peripheral Artery Disease)

MARKET DYNAMICS

The factors that drive the Global Drug Eluting Balloon for Peripheral Artery Disease Market includes rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral artery disease. For instance, according to Centre for Disease Control and Prevention, approximately 8.5 million people age 40 and older in the United States have PAD. However, stringent regulatory background may impede the market growth.

MARKET SCOPE

`
The "Global Drug Eluting Balloon for Peripheral Artery Disease Market analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Drug Eluting Balloon for Peripheral Artery Disease Market with detailed market segmentation by drug coating technology, end-users and geography. The Global Drug Eluting Balloon for Peripheral Artery Disease Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Drug Eluting Balloon for Peripheral Artery Disease Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Drug Eluting Balloon for Peripheral Artery Disease Market is segmented on the basis of drug coating technology, and end-users. On the basis of drug coating technology, the market is segmented into Paccocath, Endurocoat, Freepac, Lutonix, Stellarex. Based on end-users the market is segment into, hospitals, ambulatory surgery centers, catheterization laboratories, and others ?

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Drug Eluting Balloon for Peripheral Artery Disease Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Drug Eluting Balloon for Peripheral Artery Disease Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Drug Eluting Balloon for Peripheral Artery Disease market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drug Eluting Balloon for Peripheral Artery Disease Market in these regions.

MARKET PLAYERS

The report covers key developments in the Drug Eluting Balloon for Peripheral Artery Disease Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Drug Eluting Balloon for Peripheral Artery Disease Market are anticipated to lucrative growth opportunities in the future with the rising demand for Drug Eluting Balloon for Peripheral Artery Disease Market in the global market. Below mentioned is the list of few companies engaged in the Drug Eluting Balloon for Peripheral Artery Disease Market.

The report also includes the profiles of key Drug Eluting Balloon for Peripheral Artery Disease Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Medtronic
- Koninklijke Philips N.V.
- BD
- Cook Medical
- MEDRAD, INC. (Bayer HealthCare's)
- Eurocor
- Cardionovum

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Drug Eluting Balloon for Peripheral Artery Disease Report Scope